DRI Healthcare Trust
Company Profile
Business description
DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically the trust generates it's key revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.
Contact
100 King Street West
1 First Canadian Place, Suite 7250
TorontoONM5X 1B1
CANT: +1 416 863-1865
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
36
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,522.70 | 324.90 | -4.14% |
| CAC 40 | 7,274.95 | 324.03 | -4.26% |
| DAX 40 | 20,641.72 | 1,075.67 | -4.95% |
| Dow JONES (US) | 38,314.86 | 2,231.07 | -5.50% |
| FTSE 100 | 8,054.98 | 419.76 | -4.95% |
| HKSE | 20,373.82 | 2,475.99 | -10.84% |
| NASDAQ | 15,587.79 | 962.82 | -5.82% |
| Nikkei 225 | 31,416.19 | 2,364.39 | -7.00% |
| NZX 50 Index | 11,793.55 | 431.73 | -3.53% |
| S&P 500 | 5,074.08 | 322.44 | -5.97% |
| S&P/ASX 200 | 7,346.70 | 321.10 | -4.19% |
| SSE Composite Index | 3,130.17 | 211.84 | -6.34% |